Loeillot Olivier
SEC insider (Form 3/4/5 filer). CIK 0001995525. Chief Executive Officer at REPLIGEN CORP (RGEN). 25 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in WALTHAM, MA.
Companies Loeillot Olivier has filed insider reports for
- REPLIGEN CORP (RGEN): Director, Officer, Chief Executive Officer
Loeillot Olivier
CIK: 0001995525
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)9 (36.0%)
Position reduction
Option Exercises (M)5 (20.0%)
Derivative conversions
Awards (A)3 (12.0%)
Compensation grants
Other (G, F, J, C, D, …)8 (32.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RGEN
REPLIGEN CORP
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Oct 5, 2026RGEN
REPLIGEN CORP
SaleDirect4.2K shares at avg. $190.00$798K - Oct 5, 2026RGEN
REPLIGEN CORP
SaleDirect1.3K shares at avg. $178.75$238K - Oct 5, 2026RGEN
REPLIGEN CORP
ExerciseDirect4.2K shares at avg. $154.96$651K - Oct 2, 2026RGEN
REPLIGEN CORP
Tax PaymentDirect1.2K shares at avg. $181.70$227K - Sep 24, 2026RGEN
REPLIGEN CORP
ExerciseDirect4.5K shares at avg. $155.38$706K - Sep 24, 2026RGEN
REPLIGEN CORP
SaleDirect8.4K shares at avg. $190.00$1.6M - Sep 24, 2026RGEN
REPLIGEN CORP
SaleDirect4.5K shares at avg. $190.00$863K - Sep 24, 2026RGEN
REPLIGEN CORP
ExerciseDirect8.4K shares at avg. $154.96$1.3M - Sep 21, 2026RGEN
REPLIGEN CORP
ExerciseDirect5.4K shares at avg. $141.79$769K - Sep 21, 2026RGEN
REPLIGEN CORP
SaleDirect5.4K shares at avg. $180.00$977K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | RGEN REPLIGEN CORP | Sale | 4,202 | $190.00 | $798,380 | Direct |
| Oct 5, 2026 | RGEN REPLIGEN CORP | Sale | 1,333 | $178.75 | $238,274 | Direct |
| Oct 5, 2026 | RGEN REPLIGEN CORP | Exercise | 4,202 | $154.96 | $651,142 | Direct |
| Oct 2, 2026 | RGEN REPLIGEN CORP | Tax Payment | 1,248 | $181.70 | $226,762 | Direct |
| Sep 24, 2026 | RGEN REPLIGEN CORP | Exercise | 4,542 | $155.38 | $705,736 | Direct |
| Sep 24, 2026 | RGEN REPLIGEN CORP | Sale | 8,404 | $190.00 | $1,596,760 | Direct |
| Sep 24, 2026 | RGEN REPLIGEN CORP | Sale | 4,542 | $190.00 | $862,980 | Direct |
| Sep 24, 2026 | RGEN REPLIGEN CORP | Exercise | 8,404 | $154.96 | $1,302,284 | Direct |
| Sep 21, 2026 | RGEN REPLIGEN CORP | Exercise | 5,426 | $141.79 | $769,353 | Direct |
| Sep 21, 2026 | RGEN REPLIGEN CORP | Sale | 5,426 | $180.00 | $976,680 | Direct |
1-10 of 25 transactions